|
|
|
Volumn 24, Issue 4 Suppl 12, 1997, Pages
|
|
Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
ETOPOSIDE;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PILOT STUDY;
RADIATION DOSE;
SURVIVAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
COMBINED MODALITY THERAPY;
ETOPOSIDE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PILOT PROJECTS;
RADIOTHERAPY DOSAGE;
SURVIVAL ANALYSIS;
|
|
EID: 0031201599
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
